PROSPECTS AND OPPORTUNITIES
Rising demand driven by an ageing population, improved reimbursement policies, and increasing awareness
Rising demand for Rx/reimbursement adult incontinence products in Estonia over the next five years will be driven by an ageing population, improved reimbursement policies, and increasing awareness. As more elderly consumers require long-term incontinence solutions, demand for reimbursed products will steadily rise.
More innovation and competition expected
Over the forecast period, Estonia's Rx/reimbursement adult incontinence market will see more innovation and competition. Manufacturers like Essity AB (Tena) and Paul Hartmann AG (Molicare) are expected to introduce thinner, more absorbent, and skin-friendly materials.
Potential shift in distribution
Rx/reimbursement adult incontinence will still rely on pharmacies, medical suppliers, and healthcare institutions over the forecast years; however, growth in digitalisation and e-commerce may lead to shifts in distribution channels. Most reimbursed purchases will stay in traditional healthcare channels, but online platforms could become more popular as rules evolve and patients look for easier ways to order products.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Estonia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Estonia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Estonia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Estonia?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Estonia?
- How are products distributed in Rx/Reimbursement adult incontinence in Estonia?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Estonia - Category analysis
KEY DATA FINDINGS
Continued growth in Rx/reimbursement adult incontinence
Essity AB leads, offering a wide range of products to meet various needs
Pharmacies remain the go-to option for patients using reimbursement schemes
Rising demand driven by an ageing population, improved reimbursement policies, and increasing awareness
More innovation and competition expected
Potential shift in distribution
Tissue and Hygiene in Estonia - Industry Overview
Tissue and hygiene in 2024: The big picture
2024 key trends
Competitive landscape
Retail developments
What next for tissue and hygiene?
DISCLAIMER
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!